Skip to content

Clinical trials

Terminated Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Status: Terminated Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20034
20043
20053
20068
20073
20081
20091
20102
20117
20122
20133
20152
20162
20174
20191
20201
20211
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda10
Merck Sharp & Dohme LLC5
Pfizer3
Solvay Pharmaceuticals3
Columbia University2
Sanofi2
Amgen1
AstraZeneca1
Boston Children's Hospital1
Boston University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias55
Diabetes Mellitus12
Diabetes Mellitus, Type 212
Obesity10
Glucose Metabolism Disorders9
Diabetes Mellitus, Lipoatrophic8
Hypercholesterolemia8
Hypertension7
Hyperlipidemias6
Insulin Resistance5

Trials

Showing 51 to 55 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.